Health insurance still has strict coverage criteria for Zepbound, similar to that of Wegovy
Neither do other respectable authorities
Here are 8 potential reasons why not to prescribe Lixisenatide: 1- this is only one small study and only one dose was tested, 2- Lixisenatide is not currently available at pharmacies, 3- the weight loss associated with this GLP-1 is not desirable in many cases of Parkinsons disease where weight loss is an issue, 4- non-motor outcomes did not change as in other trials, and this will need to be better explained
Weight loss with tirzepatide varies among individuals, influenced by several factors but generally, patients can expect fairly rapid weight loss
This makes it great for patients with cyanide poisoning , as it can help as an antidote
The problem is that "units" on an insulin syringe do not directly translate to milligrams of semaglutide, and the relationship between them changes with every concentration